K Number
K122326
Manufacturer
Date Cleared
2012-11-30

(121 days)

Product Code
Regulation Number
882.4560
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The iASSIST™ Knee System is a computer assisted stereotaxic surgical instrument system to assist the surgeon in the positioning of orthopedic implant system components intra-operatively. It involves surgical instruments and position sensors to determine alignment axes in relation to anatomical landmarks and to precisely position alignment instruments and implant components relative to these axes.

Example orthopedic surgical procedures include but are not limited to: Total Knee Arthroplasty.

Device Description

The iASSIST Knee System consists of tracking sensors, a computer system, software, and surgical instruments designed to assist the surgeon in the placement of Total Knee Replacement components.

The tracking sensors combined with the surgical instruments provide positional information to help orient and locate the main femoral and tibial cutting planes as required in knee replacement surgery. This includes means for the surgeon to determine and thereafter track each of the bones' alignment axes relative to which the cutting planes are set. The computer system and software components control and sequence the functions of the sensors per the applicable knee surgery steps via wireless communication.

AI/ML Overview

Here's a breakdown of the acceptance criteria and the study details for the iASSIST™ Knee System, based on the provided text:

Acceptance Criteria and Device Performance

Acceptance Criteria (Design Requirement)Reported Device Performance
Overall Hip-Knee-Ankle alignments within ±3° of target in 90% of cases"demonstrated satisfactory performance per the intended use including obtaining overall Hip-Knee-Ankle alignments within ±3° of target in 90% of the cases per design requirements."

Study Details

  1. Sample size used for the test set and the data provenance:

    • Sample Size: Not explicitly stated as a numerical count of cases, but implied within "multiple surgeons" performing "Full use simulations tests using cadaver specimens or sawbones."
    • Data Provenance: The tests were "performed under simulated bench test conditions" and "using cadaver specimens or sawbones." This indicates prospective, simulated lab data, not retrospective human clinical data from a specific country of origin.
  2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Number of Experts: "multiple surgeons"
    • Qualifications of Experts: The text refers to "surgeons," implying they are qualified medical doctors specialized in orthopedic surgery, particularly Total Knee Arthroplasty. No further specific qualifications (e.g., years of experience) are provided.
  3. Adjudication method for the test set:

    • The document does not explicitly describe an adjudication method (like 2+1, 3+1). The evaluation seems to be based on the system's ability to achieve the target alignment as measured by the surgeons during the simulation.
  4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • No MRMC comparative effectiveness study is mentioned. The study described is a performance verification of the device itself under simulated conditions, not a comparison of human reader performance with and without AI assistance. The device assists the surgeon; it doesn't replace their interpretation or decision-making in a diagnostic sense.
  5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    • The device is explicitly described as a "computer assisted stereotaxic surgical instrument system to assist the surgeon." It is designed for use with a human surgeon. Therefore, a standalone (algorithm only) performance assessment, disconnected from the surgeon's interaction, is not applicable or described in this context. The "Performance tests" assessed aspects like "calibration, femur registration, tibia registration, tibia navigation, femur navigation, and tibia & femur cut validation," which are components contributing to the assisted surgical process.
  6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    • The ground truth for the "Overall Hip-Knee-Ankle alignments" was the target alignment (within ±3°). This target is a predefined surgical goal. The measurement of whether this target was met would likely be determined by reference instruments or techniques during the cadaver/sawbones simulations.
  7. The sample size for the training set:

    • The document does not specify a training set sample size. The description of "Performance tests" and "Full use simulations" relates to testing and verification rather than training of algorithms.
  8. How the ground truth for the training set was established:

    • Since no training set is explicitly mentioned or described, the method for establishing its ground truth is also not provided. The document focuses on the performance and verification of the system's software algorithms and overall function.

{0}------------------------------------------------

K122326

21

12

510(K) SUMMARY OF SAFETY AND EFFECTIVENESS iASSIST™ KNEE SYSTEM

Applicant: Zimmer CAS 75 Queen Street, suite 3300 Montreal, Quebec Canada, H3C 2N6 Tel .: 514 861 4074 Fax: 514 866 2197

Contact Person: Christopher McLean

Date Summary Prepared: November 9, 2012

Device Trade Name: iASSIST™ Knee System

Device Classification Name: Orthopedic Stereotaxic Instrument (product code OLO); 21 CFR § 882.4560

Predicate Device:

KneeAlign 2 System, form OrthAlign Inc., 510(k) # K103829

Device Description:

The iASSIST Knee System consists of tracking sensors, a computer system, software, and surgical instruments designed to assist the surgeon in the placement of Total Knee Replacement components.

The tracking sensors combined with the surgical instruments provide positional information to help orient and locate the main femoral and tibial cutting planes as required in knee replacement surgery. This includes means for the surgeon to determine and thereafter track each of the bones' alignment axes relative to which the cutting planes are set. The computer system and software components control and sequence the functions of the sensors per the applicable knee surgery steps via wireless communication.

Indications for Use / Intended Use:

The iASSIST Knee System is a computer assisted stereotaxic surgical instrument system to assist the surgeon in the positioning of orthopedic implant system components intra-operatively. It involves surgical instruments and position sensors to determine alignment axes in relation to anatomical landmarks and to precisely position alignments and implant components relative to these axes.

Example orthopedic surgical procedures include but are not limited to: Total Knee Arthroplasty.

Technological Comparisons to the Predicates:

The main technology in the iASSIST Knee system is the predicate. In both cases accelerometer and gyroscope based (inertial) sensors are assembled or combined with manual surgical instruments to provide navigation information for the manual placement of orthopedic implants intra-operatively, with the operation and functions of the sensors being computer controlled. Both systems involve providing the same navigation information for the same femoral and tibial cutting planes for knee replacement surgery. Other implementation methods are similar between both systems

{1}------------------------------------------------

  • similar software algorithm and hardware to sequence and control the sensors and user . interface functions via wireless communication,
  • similar software and instrument features to determine and track the alignment axes to . reference the cutting planes,
  • · similar instrument features and functions to allow assembly of the sensors, to attach the subject bones, to register or digitize the applicable landmarks, and to adjust the alignment of provided saw guides,

Performance Data:

Non-clinical tests were performed to assess that no new safety and efficacy issues were raised in the device. The main tests included the following.

    1. Biocompatibility tests were performed on the tracking sensor devices to ensure that the use of membrane switch interfaces with encapsulated LEDS does not involve any bioincompatible effects. These involved cytotoxicity (MEM Elution), irritation (Intracutaneous Sensitivity), and systemic toxicity (Maximization) tests in accordance with ISO 10993-1 for either Externally Communicating or Implant type device with tissue/bone contact up to 24 hours. Materials with established biocompatibility characteristics were used in the reminder of the patient contact instruments.
    1. Software System tests were performed to ensure that no hazardous anomalies were present in the system software components. They consisted of testing software features and functionalities in correspondence to software design requirements. They included the hardware interfaces, the use of the tracking sensor and instruments as applicable, the verification of fault conditions, and installation tests.
    1. Performance tests were performed under simulated bench test conditions to verify the implementation of the software algorithms and the system accuracy for each accuracy related function: calibration, femur registration, tibia registration, tibia navigation, femur navigation, and tibia & femur cut validation.
    1. Full use simulations tests using cadaver specimens or sawbones were performed by multiple surgeons to verify and validate the overall system performance in terms of system usage and instrument ergonomics. The results demonstrated satisfactory performance per the intended use including obtaining overall Hip-Knee-Ankle alignments within ±3° of target in 90% of the cases per design requirements.
    1. Electrical, electromagnetic compatibility, and wireless telecommunication tests were performed to demonstrate compliance to IEC 60601-1-2, and FCC 47 CFR part 15.
    1. Sterilization and packaging validation tests as applicable for the Tracking Sensors which are provided sterile using Ethylene Oxide were performed in compliance with ISO 11135 and ISO 11607 respectively to ensure and maintain an SAL of 10° over the over the shelf life of the product.

Conclusion:

The information and data provided in this 510(k) Premarket Notification established that the iASSIST Knee System is substantially equivalent to the predicate.

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes representing the three levels of government: federal, state, and local. The eagle is encircled by the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002

Zimmer

% Mr. Christopher McLean Quality and Regulatory Affairs Associate Director 75 Queen Street, Suite 3300 Montreal, Canada H3C 2N6

Re: K122326

Trade/Device Name: iAssist™ Knee System Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: Class II Product Code: OLO Dated: November 09, 2012 Received: November 13, 2012

November 30, 2012

Dear Mr. McLean:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{3}------------------------------------------------

Page 2 – Mr. Christopher McLean

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Peter D. Rumm -S

Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

510(k) Number:

Device Name: iASSIST™ Knee System

Indications for Use:

The iASSIST™ Knee System is a computer assisted stereotaxic surgical instrument system to assist the surgeon in the positioning of orthopedic implant system components intra-operatively. It involves surgical instruments and position sensors to determine alignment axes in relation to anatomical landmarks and to precisely position alignment instruments and implant components relative to these axes.

Example orthopedic surgical procedures include but are not limited to: Total Knee Arthroplasty.

Prescription Use_ > (per 21CFR 801.109) Over-the-Counter Use

Concurrence of CDRH, Office of Device Evaluation (ODE)

Neil R.P. Ogden2012.11.30
10:44:16 -05'00'

OR

Division Sign-Off) Division of Surgicul Devices SIO(k) Number

§ 882.4560 Stereotaxic instrument.

(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).